In-line monitoring of carvedilol crystallization using raman spectroscopy

Crystal Growth and Design

Volumn 12, Issue 11, 2012, Pages 5621-5628

  Pataki, Hajnalka ^a   Markovits, Imre ^b   Vajna, Balázs ^a   Nagy, Zsombor K ^a   Marosi, György ^a  

^a BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS   (Hungary)

^b EGIS PHARMACEUTICALS LTD   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; COOLING CRYSTALLIZATION; DRUG CONCENTRATION; ETHYL ACETATES; IN-LINE MONITORING; INDUSTRIAL CRYSTALLIZATION; METHYL KETONES; POLYMORPHIC TRANSITIONS; REAL-TIME RAMAN SPECTROSCOPY; RISING TEMPERATURES; THERMODYNAMICALLY STABLE; TRANSITION RATES;

ACETONE;

RAMAN SPECTROSCOPY;

EID: 84868687114     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg301135z     Document Type: Article

References (30)

1. Bernstein, J. Polymorphism in Molecular Crystals; Clarendon Press: Oxford, 2002.
2. Zhang, G. Z.; Law, D.; Schmitt, E. A.; Qiu, Y. Adv. Drug Delivery Rev. 2004, 56, 371-390
3. Rezende, R. L. O.; Santoro, M. I. R. M.; Matos, J. R. J. Therm. Anal. Calorim. 2008, 93, 881-886
4. Német, Z.; Sztatisz, J.; Demeter, á. J. Pharm. Sci. 2008, 97, 3222-3232
5. Auer, M. E.; Griesser, U. J.; Sawatzki, J. J. Mol. Struct. 2003, 307, 661-662
6. Fujiwara, M.; Chow, P. S.; Ma, D. L.; Braatz, R. D. Cryst. Growth Des. 2002, 2, 363-370
7. Févotte, G.; Calas, J.; Puel, F.; Hoff, C. Int. J. Pharm. 2004, 273, 159-169
8. De Beer, T.; Burggraeve, A.; Fonteyne, M.; Saerens, L.; Remon, J. P.; Vervaet, C. Int. J. Pharm. 2011, 417, 32-47
9. Févotte, G. Chem. Eng. Res. Des. 2007, 85, 906-920
10. Wikström, H.; Kakidas, C.; Taylor, L. S. J. Pharmaceut. Biomed. 2009, 49, 247-252
11. Wikström, H.; Rantanen, J.; Gift, A. D.; Taylor, L. S. Cryst. Growth Des. 2008, 8, 2684-2693
12. Doki, N.; Seki, H.; Takano, K.; Asatani, H.; Yokota, M.; Kubota, N. Cryst. Growth Des. 2004, 4, 949-953
13. Kempkes, M.; Eggers, J.; Mazzotti, M. Chem. Eng. Sci. 2008, 63, 4656-4675
14. Zhoua, Y.; Srinivasana, R.; Lakshminarayanan, S. Comput. Chem. Eng. 2009, 33, 1022-1035
15. Shukla, A.; Prakash, A.; Rohani, S. Chem. Eng. Sci. 2010, 65, 3072-307
16. Benes, P.; Klusacek, S.; Pikal, P. Proc. IEEE Sens. 2004, 1, 357-360
17. Vankeirsbilck, T.; Vercauteren, A.; Baeyens, W.; Van der Weken, G.; Verpoort, F.; Vergote, G.; Remon, J. P. Trends Anal. Chem. 2002, 21, 869
18. Chen, J.; Sarma, B.; Evans, J. M. B.; Myerson, A. S. Cryst. Growth Des. 2011, 11, 887-895
19. Wang, F.; Wachter, J. A.; Antosz, F. J.; Berglund, K. A. Org. Process Res. Dev. 2000, 4, 391-395
20. Falcon, J. A.; Berglund, K. A. Cryst. Growth Des. 2004, 457-463, 4(3)
21. Jiang, S.; H. ter Horst, J.; Jansens, P. J. Cryst. Growth Des. 2008, 8, 37-43
22. FDA. Guidance for Industry: PAT-A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance; Office of Training and Communication, Division of Drug Information, HFD-240, Center for Drug Evaluation and Research, Food and Drug Administration: Rockville, MD, September 29, 2004.
23. Yu, L. X.; Lionberger, R. A.; Raw, A. S.; DCosta, R.; Wu, H.; Hussain, A. S. Adv. Drug Delivery Rev. 2004, 56, 349-369
24. Hishamuddin, E.; Stapley, A. G. S.; Nagy, Z. K. J. Cryst. Growth 2011, 335, 172-180
25. Simon, L. L.; Oucherif, K. A.; Nagy, Z. K.; Hungerbuhler, K. Chem. Eng. Sci. 2010, 65, 4983-4995
26. Saleemi, A. N.; Rielly, C. D.; Nagy, Z. K. Cryst. Growth Des. 2012, 12, 1792-1807
27. Gendrin, C.; Roggo, Y.; Collet, C. J. Pharm. Biomed. Anal. 2008, 48, 533-553
28. Vajna, B.; Patyi, G.; Nagy, Zs. K.; Bódis, A.; Farkas, A.; Marosi, Gy. J. Raman Spectrosc. 2011, 42, 1977-1986
29. Ono, T.; Kramer, H. J. M.; ter Horst, J. H.; Jansens, P. J. Cryst. Growth Des. 2004, 4, 1161-1167
30. Patent of TEVA Pharmaceutical Industries, WO 02/00216 A1, 2002.